ConductScience.org, home

Paper40649751

Tumor-Associated Macrophage in Breast Tumor Microenvironment.

Ma L and 3 others. Int J Mol Sci, 2025. Cited by 5 papers, by iCite.

Cite this record

ConductScience Library. Tumor-Associated Macrophage in Breast Tumor Microenvironment. Papers, record 40649751. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40649751

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Tumor-Associated Macrophage in Breast Tumor Microenvironment.
PubMed
Journal
Int J Mol Sci
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
5
iCite
Relative citation ratio, by iCite
1.18, provisional
iCite
Revised in PubMed
2025-07-16
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ma LLingyao
2Jin YYuexinzi
3Xu JJian
4Zhang JJiexinhttps://orcid.org/0000-0003-1407-7562

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Tumor MicroenvironmentMajor topic
Breast NeoplasmsMajor topic
Tumor-Associated MacrophagesMajor topic
Humans
Female
Animals
Neovascularization, Pathologic

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
81501817the National Natural Science Foundation of ChinaPubMed
82202610the National Natural Science Foundation of ChinaPubMed
ZDXK202239the Jiangsu Province Capability Improvement Project through Science, Technology and EducationPubMed

Source PubMed

Download CSV of grants

References238

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
125035124Targeting cancer-derived adenosine: new therapeutic approaches.Cancer Discov2014https://conductscience.org/library/papers/25035124PubMed
227562774Diverse macrophages polarization in tumor microenvironment.Arch Pharm Res2016https://conductscience.org/library/papers/27562774PubMed
327271610Hypoxia Inducible Factor 1 (HIF-1) Recruits Macrophage to Activate Pancreatic Stellate Cells in Pancreatic Ductal Adenocarcinoma.Int J Mol Sci2016https://conductscience.org/library/papers/27271610PubMed
434678411ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer.Ann Oncol2021https://conductscience.org/library/papers/34678411PubMed
531429357The Angiopoietin ligands and Tie receptors: potential diagnostic biomarkers of vascular disease.J Recept Signal Transduct Res2019https://conductscience.org/library/papers/31429357PubMed
636333630NRP1 contributes to stemness and potentiates radioresistance via WTAP-mediated m6A methylation of Bcl-2 mRNA in breast cancer.Apoptosis2023https://conductscience.org/library/papers/36333630PubMed
730728668Single Cell Omics of Breast Cancer: An Update on Characterization and Diagnosis.Indian J Clin Biochem2019https://conductscience.org/library/papers/30728668PubMed
816169466Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors.Cancer Cell2005https://conductscience.org/library/papers/16169466PubMed
926612575Addendum: A breast cancer stem cell niche supported by juxtacrine signalling from monocytes and macrophages.Nat Cell Biol2015https://conductscience.org/library/papers/26612575PubMed
1029849822CXCR4/CXCL12 Signaling and Protumor Macrophages in Primary Tumors and Sentinel Lymph Nodes Are Involved in Luminal B Breast Cancer Progression.Dis Markers2018https://conductscience.org/library/papers/29849822PubMed
1135168767Disparities in Breast Cancer.Obstet Gynecol Clin North Am2022https://conductscience.org/library/papers/35168767PubMed
1224912655CSF-1R signaling in health and disease: a focus on the mammary gland.J Mammary Gland Biol Neoplasia2014https://conductscience.org/library/papers/24912655PubMed
1327745970L-Arginine Modulates T Cell Metabolism and Enhances Survival and Anti-tumor Activity.Cell2016https://conductscience.org/library/papers/27745970PubMed
1421481792Targeting the ANG2/TIE2 axis inhibits tumor growth and metastasis by impairing angiogenesis and disabling rebounds of proangiogenic myeloid cells.Cancer Cell2011https://conductscience.org/library/papers/21481792PubMed
1528974683Caspase-1 cleaves PPARγ for potentiating the pro-tumor action of TAMs.Nat Commun2017https://conductscience.org/library/papers/28974683PubMed
1625959051Human breast cancer invasion and aggression correlates with ECM stiffening and immune cell infiltration.Integr Biol (Camb)2015https://conductscience.org/library/papers/25959051PubMed
1731720082Recruitment of monocytes and epigenetic silencing of intratumoral CYP7B1 primarily contribute to the accumulation of 27-hydroxycholesterol in breast cancer.Am J Cancer Res2019https://conductscience.org/library/papers/31720082PubMed
1829902924Cancer stem cells in triple-negative breast cancer: a potential target and prognostic marker.Biomark Med2018https://conductscience.org/library/papers/29902924PubMed
1935469015Perivascular tenascin C triggers sequential activation of macrophages and endothelial cells to generate a pro-metastatic vascular niche in the lungs.Nat Cancer2022https://conductscience.org/library/papers/35469015PubMed
2033150908A parallel and cascade control system: magnetofection of miR125b for synergistic tumor-association macrophage polarization regulation and tumor cell suppression in breast cancer treatment.Nanoscale2020https://conductscience.org/library/papers/33150908PubMed

See all 238 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.

PMIDTitleJournalYearIn PapersSource
42513228Breast Cancer: Epidemiology, Molecular Classification, Diagnostics and Evolving Treatment Paradigms.Molecules2026https://conductscience.org/library/papers/42513228PubMed
42212312Targeting Tumor-Associated Macrophages to Reshape the Immuno-Mechanical Landscape: Molecular Mechanisms and Therapeutic Strategies.Int J Biol Sci2026https://conductscience.org/library/papers/42212312PubMed
42093035The ARTEMIS trial identifies immune activation as a key predictor of neoadjuvant chemotherapy response in triple-negative breast cancer.Breast Cancer Res2026https://conductscience.org/library/papers/42093035PubMed
41001838Comprehensive Pan-Cancer Analysis of TRNT1 as a Potential Biomarker for Breast Cancer.J Cell Mol Med2025https://conductscience.org/library/papers/41001838PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40649751

GET https://conductscience.org/api/papers/v1/40649751/references?page=2